Screener
Twist Bioscience Corporation TWST Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesFairValueDisclosure.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
| (in thousands) | Level 1 | Level 2 | Level 3 | Fair value |
|---|---|---|---|---|
| Assets | ||||
| Money market funds | $89,187 | — | — | $89,187 |
| U.S. government treasury bills | 49,001 | — | — | 49,001 |
| Total financial assets | $138,188 | — | — | $138,188 |
| Liabilities | ||||
| Liability for issuance of shares of common stock | — | — | 5,000 | 5,000 |
| Total financial liabilities | — | — | $5,000 | $5,000 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Twist Bioscience Corporation's total liabilities?
- Twist Bioscience Corporation (TWST) reported total liabilities of $5M in Q1 2026.
- How has Twist Bioscience Corporation's total liabilities changed year-over-year?
- Twist Bioscience Corporation's total liabilities decreased by 96.8% year-over-year, from $155.51M to $5M.
- What is the long-term trend for Twist Bioscience Corporation's total liabilities?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's total liabilities has grown at a 103.5% compound annual growth rate (CAGR), from $9.86M to $168.9M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Twist Bioscience Corporation's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude